Traitement des amyloses AL systémiques: à propos de 25 cas

Primarye systemic AL amyloidosis is a rare hematologic disorder. The majority of the therapeutic guidelines are based on phase II studies or on retrospective comparisons and case series. Our study aimed to describe all the cases of primary AL amyloidosis reported in 2 military hospitals and to make...

Descripción completa

Detalles Bibliográficos
Autores principales: Eddou, Hicham, Zinebi, Ali, Maaroufi, Hicham El, Moudden, Mohammed Karim, Doghmi, Kamal, Mikdame, Mohammed, Baaj, Mohammed El
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The African Field Epidemiology Network 2017
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5847059/
https://www.ncbi.nlm.nih.gov/pubmed/29541306
http://dx.doi.org/10.11604/pamj.2017.28.160.11885

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5847059/
https://www.ncbi.nlm.nih.gov/pubmed/29541306
http://dx.doi.org/10.11604/pamj.2017.28.160.11885

Ejemplares similares